.

. - FLASH

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2014-005575-84-FR

Enrollment

826

Registered

2015-06-25

Start date

2015-08-25

Completion date

Unknown

Last updated

2019-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Product Name: Voluven® Pharmaceutical Form: Solution for injection INN or Proposed INN: VOLUVEN® hydroxyéthylamidon 130 000 sol p perf CAS Number: B05AA

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: . Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 600 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 226

Exclusion criteria

Exclusion criteria: .

Design outcomes

Primary

Measure	Time frame
Main Objective: .;Secondary Objective: .;Primary end point(s): .;Timepoint(s) of evaluation of this end point: .	—

Secondary

Measure	Time frame
Secondary end point(s): .;Timepoint(s) of evaluation of this end point: .	—

Countries

France

Contacts

Public ContactDélégation à la Recherche Clinique

CHU de Clermont-Ferrand

placarin@chu-clermontferrand.fr00330473751195

Outcome results